Today: 17 November 2025
Subscribe
Browse Category

Market Analysis News 3 November 2025 - 4 November 2025

Nasdaq Stumbles as Fed Jitters Mount, Intel Soars, Tariffs Rattle Tech Markets

AI Rally Hits Speed Bump as Futures Fall – Key Facts Before the Nov. 4 Market Open

U.S. Futures Slide as Tech Rally Stalls Stock index futures are firmly in the red before the opening bell, indicating Wall Street will give back some of Monday’s gains. S&P 500 futures are down roughly 0.9% and Nasdaq 100 futures off 1.2%, with Dow futures –0.7% seekingalpha.com seekingalpha.com. This comes after the Nasdaq Composite and S&P 500 ticked higher yesterday, buoyed by excitement over a big Amazon–OpenAI AI partnership, even as the Dow slipped economictimes.indiatimes.com. That optimism has proved short-lived; by early Tuesday, futures reversed as investors refocus on stretched valuations in the tech sector and worry that the AI
4 November 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Amazon’s $38 Billion OpenAI Deal Makes Bezos $10 B Richer and Ignites the AI Cloud Wars

Amazon’s $38 Billion OpenAI Deal Makes Bezos $10 B Richer and Ignites the AI Cloud Wars

AWS and OpenAI Ink a $38 Billion Cloud Partnership Amazon Web Services and OpenAI unveiled a multi-year cloud computing deal that ranks among the largest ever in tech. Under the agreement – valued at $38 billion over seven years – OpenAI will run and scale its advanced AI workloads on AWS’s “world-class infrastructure” starting immediately aboutamazon.com. In practical terms, AWS is provisioning OpenAI with vast computing capacity: on day one, OpenAI gains access to hundreds of thousands of NVIDIA GPU-based processors in AWS data centers, with the option to scale up to tens of millions of CPU cores for future growth arabianbusiness.com.
4 November 2025
 ·  ·  ·  · 
Bitcoin Plunges Below $107K as Crypto Markets Reset – Experts See “Controlled” Dip

Bitcoin’s $100K Rollercoaster: Wild Swings, Big News, and Bold 2025 Crypto Forecasts

Bitcoin Price Snapshot: Early November 2025 Bitcoin enters November 2025 on a shaky footing yet remarkable footing: prices are holding around $106,000–$107,000 as of November 4, after a volatile start to the month that saw BTC briefly plunge under $105K crypto.news. Just days ago, Bitcoin was changing hands above $110K; the swift drop has erased roughly 14% from its recent local high cryptorank.io business-standard.com. This volatility comes on the heels of an explosive October: Bitcoin rallied to a record ~$126,000 on Oct. 6 during a late-year surge, before a sharp reversal set in crypto.news. In fact, BTC has now lost
4 November 2025
 ·  ·  ·  · 
Ethereum’s Nov 3 Price Plunge: Fed Jitters & $110M Hack Rock ETH – Is a Rebound Ahead?

Ethereum’s Nov 3 Price Plunge: Fed Jitters & $110M Hack Rock ETH – Is a Rebound Ahead?

Ethereum (ETH) experienced a turbulent trading session on November 3, 2025, amid a wave of bearish news and market-wide sell-offs. The second-largest cryptocurrency saw its price swing wildly before closing sharply lower, as investors reacted to hawkish signals from the U.S. Federal Reserve and a major DeFi exploit on the Ethereum network. Below, we break down the day’s key price action, the top news headlines shaking the crypto markets, expert insights on what it all means, and what might lie ahead for Ethereum in both the short and long term. Key Facts Ethereum Price Action on November 3, 2025 On
4 November 2025
 ·  ·  ·  · 
Solana (SOL) Price Rollercoaster: From $250 Uptober High to $185 – Will It Rebound to $300?

Solana’s Meteoric Rise: $175 Price, Game-Changing Upgrades & Wall Street’s Big Crypto Bet

SOL Price Trends and Market Performance (Nov 2025) After a tremendous rally earlier in 2025, Solana’s price is currently hovering around $175–$180 per token coinmarketcap.com. At this price, Solana’s market capitalization is in the ~$100 billion range coinmarketcap.com, firmly cementing it as a top-tier cryptocurrency (6th largest by market cap as of this week). Trading volumes remain healthy; for example, recent daily volume has been on the order of $3–8 billion USD coinmarketcap.com coinmarketcap.com, indicating significant liquidity and investor interest. Recent Price Action: SOL’s price has seen notable volatility in late October and early November 2025. Just last week, Solana
3 November 2025
 ·  ·  ·  · 
Cryptocurrency Market Update: October 2025 Rally Ends with Tariff-Driven Selloff

Crypto Market Bloodbath: Fed Bombshell Triggers Bitcoin & Ethereum Plunge on Nov 3, 2025

Fed’s Hawkish Surprise Sparks a Sell-Off A macroeconomic curveball from the U.S. Federal Reserve set the tone for the crypto downturn. Late last week, the Fed delivered a widely expected 0.25% interest rate cut – normally a bullish sign for risk assets – but Chair Jerome Powell’s commentary after the meeting came in far more hawkish than traders hoped. Powell cautioned that another rate cut in December is “not a foregone conclusion,” explicitly pushing back on market expectations of a quick easing cycle binance.com. This hawkish Fed bombshell immediately soured sentiment across markets, boosting the dollar and prompting investors to
3 November 2025
 ·  ·  ·  · 
Axsome Therapeutics (AXSM) Skyrockets on CNS Breakthroughs: Stock Surge, Pipeline Wins, and 2025 Outlook

Axsome Therapeutics (AXSM) Skyrockets on CNS Breakthroughs: Stock Surge, Pipeline Wins, and 2025 Outlook

Stock Performance and Recent Trend Axsome’s stock has been a standout performer in 2025. As of November 3, 2025, AXSM trades around $134–$135 per share, roughly doubling from its 52-week low of $75.56 finviz.com. The stock has gained about 60% year-to-date and 52% over the past year seattlepi.com – a remarkable run that far outpaces the broader biotech sector and the S&P 500. This surge reflects growing investor optimism as Axsome transforms into a commercial-stage company with multiple marketed drugs. Recent trading momentum: In the days leading up to Nov 3, AXSM shares climbed steadily, likely in anticipation of strong
3 November 2025
 ·  ·  ·  ·  · 
CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors?

CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors?

High-Flying Share Price and Recent Performance 🚀 As of November 3, 2025, CURE Pharmaceutical’s stock is trading around $3.6 per share, reflecting an explosive rise in late October. On Friday, Oct 31, the stock closed at $3.78, up from $2.89 the day prior stockinvest.us. That single-day gain of +30.8% crowned CURR (now AVRW) as one of the market’s top percentage gainers. In fact, the stock has rallied five days in a row, more than doubling (+104% in two weeks) amid surging volume stockinvest.us. This momentum continued into Nov 3, with an opening trade around $3.52 and only a modest pullback
3 November 2025
 ·  ·  ·  · 
Nocera (NCRA) Stock Skyrockets 36% on $300M Digital Asset Deal – Key Facts & Outlook

Nocera (NCRA) Stock Skyrockets 36% on $300M Digital Asset Deal – Key Facts & Outlook

Company Overview and Business Model Nocera is a small-cap company that began in the aquaculture technology niche. It designs and builds land-based recirculating aquaculture systems (RAS) – essentially the tanks, filtration equipment, and engineering needed for sustainable fish farms stockanalysis.com. Founded in 2014 and based in New Taipei City, Taiwan, Nocera provided engineering, procurement, and construction services to fish farming projects, aiming to make seafood production more efficient on land stockanalysis.com. In 2023–2024, Nocera branded itself as a “fully integrated sustainable seafood company,” but it has since broadened its scope. Now the firm calls itself “dynamic, industry-agnostic, and acquisition-focused,” seeking
3 November 2025
 ·  ·  ·  ·  · 
TG Therapeutics Stock Soars on Briumvi Boom – Key Facts, Analyst Insights & 2025 Outlook

TG Therapeutics Stock Soars on Briumvi Boom – Key Facts, Analyst Insights & 2025 Outlook

Company Overview: Briumvi-Focused Business Model TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in treatments for B-cell mediated diseases gurufocus.com. After years as a development-stage biotech, TG entered the commercial arena with Briumvi, its first approved product, and now generates the majority of revenue from Briumvi sales in the U.S. gurufocus.com. The company’s strategy centers on leveraging its expertise in B-cell biology to address both autoimmune disorders and B-cell cancers. Briumvi – A Breakthrough in Multiple Sclerosis Therapy Briumvi (ublituximab-xiiy) is TG’s flagship drug, approved by the FDA in December 2022 for adults with relapsing forms of multiple sclerosis
3 November 2025
 ·  ·  ·  ·  · 
NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO Stock Performance: Latest Price and Short-Term Trend NIO’s stock has been on a notable upswing heading into November 2025. Shares closed at $7.25 on October 31, 2025 – a multi-month high – after jumping over 3% in a single day following the latest delivery report stockinvest.us. This capped a strong week; NIO gained roughly 5.1% over the last week of October, even though it was still down a few percent over the full month simplywall.st. The late-October bounce reflects renewed investor enthusiasm around the company’s record sales figures and growth trajectory. It’s worth noting that NIO’s current price around
3 November 2025
 ·  ·  ·  ·  · 
Palantir Stock Skyrockets on Massive UK AI-Defense Pact – Could PLTR Eclipse Oracle by 2030?

Palantir Stock Skyrockets to New Highs: Inside PLTR’s AI-Fueled Surge and What’s Next

Detailed Report Palantir Stock Soars to Record Highs Ahead of Earnings Palantir’s stock price has been on a tear, surging to new all-time highs as of early November 2025. As of November 3, 2025, PLTR trades around $200 per share, having gained roughly 3% in the past day and even more in pre-market trading finbold.com. The stock briefly touched $204.18 intraday last week – its highest price ever tradingview.com. This marks an incredible run-up from just a year ago; Palantir shares have climbed about 370% year-over-year, and are up roughly 150% since January alone. Such momentum has swelled Palantir’s market
3 November 2025
 ·  ·  ·  ·  · 
1 … 13 14 15 16 17 … 45
Go toTop